Clinical Trial Update: Postoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC Greater Than 6 Weeks After Surgery [NA]

View source ↗

Summary

A Wake Forest trial is evaluating postoperative radiotherapy for intermediate- and high-risk head and neck squamous cell carcinoma patients more than six weeks …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma HNSCC | NA | Status: RECRUITING